Recognizing lung disease in patients with rheumatoid arthritis, part 1

Journal of Respiratory Diseases

Volumn 29, Issue 7, 2008, Pages 274-280

  Antin Ozerkis, Danielle ^a   Rubinowitz, Ami ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Diagnostic Imaging ^*

Author keywords

Interstitial lung disease; Rheumatoid arthritis

Indexed keywords

AZATHIOPRINE; CARBON MONOXIDE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; FIBRINOLYTIC AGENT; IMMUNOSUPPRESSIVE AGENT; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

BRONCHIECTASIS; BRONCHIOLITIS OBLITERANS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DYSPNEA; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG BIOPSY; LUNG DIFFUSION CAPACITY; LUNG DISEASE; LUNG EMPHYSEMA; LUNG FUNCTION TEST; LUNG INFECTION; LUNG LAVAGE; PLEURA EFFUSION; PNEUMOTHORAX; PROGNOSIS; REVIEW; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; SYMPTOMATOLOGY; THORACOCENTESIS; TUBERCULOUS EMPYEMA; UNSPECIFIED SIDE EFFECT;

EID: 49049119701     PISSN: 0194259X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-324.
2. Spector TD. Rheumatoid arthritis. Rheum Dis Clin North Am. 1990;16:513-537.
3. Costenbader KH, Feskanich D, Mandl LA, Karlson EW. Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women. Am J Med. 2006;119:503.e1-503.e9.
4. Wolfe F, Freundlich B, Straus WL. Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol. 2003;30:36-40.
5. Meune C, Wahbi K, Assous N, et al. Myocardial dysfunction in rheumatoid arthritis: a controlled tissue-Doppler echocardiography study. J Rheumatol. 2007;34:2005-2009.
6. Freemer M, King TE. Connective tissue diseases. In: Schwarz MI, King TE, eds. Interstitial Lung Disease. 4th ed. London: BC Decker Inc; 2003:535-598.
7. Metafratzi ZM, Georgiadis AN, Ioannidou CV, et al. Pulmonary involvement in patients with early rheumatoid arthritis. Scand J Rheumatol. 2007;36:338-344.
8. Allan JS, Donahue DM, Garrity JM. Rheumatoid pleural effusion in the absence of arthritic disease. Ann Thorac Surg. 2005;80:1519-1521.
9. Balbir-Gurman A, Yigla M, Nahir AM, Braun-Moscovici Y. Rheumatoid pleural effusion. Semin Arthritis Rheum. 2006;35:368-378.
10. Gauhar UA, Gaffo AL, Alarcón GS. Pulmonary manifestations of rheumatoid arthritis. Semin Respir Crit Care Med. 2007;28:430-440.
11. Tanoue LT. Pulmonary manifestations of rheumatoid arthritis. Clin Chest Med. 1998;19:667-685, viii.
12. Pritikin JD, Jensen WA, Yenokida GG, et al. Respiratory failure due to a massive rheumatoid pleural effusion. J Rheumatol. 1990;17:673-675.
13. Joseph J, Sahn SA. Connective tissue diseases and the pleura. Chest. 1993;104:262-270.
14. Dodson WH, Hollingsworth JW. Pleural effusion in rheumatoid arthritis. Impaired transport of glucose. N Engl J Med. 1966;275:1337-1342.
15. Engel U, Aru A, Francis D. Rheumatoid pleurisy. Specificity of cytological findings. Acta Pathol Microbiol Immunol Scand [A]. 1986;94:53-56.
16. Yarbrough JW, Sealy WC, Miller JA. Thoracic surgical problems associated with rheumatoid arthritis. J Thorac Cardiovasc Surg. 1975;69:347-354.
17. Gotsman I, Goral A, Nusair S. Secondary spontaneous pneumothorax in a patient with pulmonary rheumatoid nodules during treatment with methotrexate. Rheumatology (Oxford). 2001;40:350-351.
18. Morrison SC, Mody GM, Benatar SR, Meyers OL. The lungs in rheumatoid arthritis - a clinical, radiographic and pulmonary function study. S Afr Med J. 1996;86:829-833.
19. Gochuico BR, Avila NA, Chow CK, et al. Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med. 2008;168:159-166.
20. Dawson JK, Fewins HE, Desmond J, et al. Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests. Thorax. 2001;56:622-627.
21. Suzuki A, Ohosone Y, Obana M, et al. Cause of death in 81 autopsied patients with rheumatoid arthritis. J Rheumatol. 1994;21:33-36.
22. Akira M, Sakatani M, Hara H. Thin-section CT findings in rheumatoid arthritis-associated lung disease: CT patterns and their courses. J Comput Assist Tomogr. 1999;23:941-948.
23. Kocheril SV, Appleton BE, Somers EC, et al. Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia. Arthritis Rheum. 2005;53:549-557.
24. Tanaka N, Kim JS, Newell JD, et al. Rheumatoid arthritis-related lung diseases: CT findings. Radiology. 2004;232:81-91.
25. Flaherty KR, Thwaite EL, Kazerooni EA, et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax. 2003;58:143-148.
26. Lynch DA, David Godwin J, Safrin S, et al. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med. 2005;172:488-493.
27. Hunninghake GW, Zimmerman MB, Schwartz DA, et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2001;164:193-196.
28. Devaraj A, Wells AU, Hansell DM. Computed tomographic imaging in connective tissue diseases. Semin Respir Crit Care Med. 2007;28:389-397.
29. Biederer J, Schnabel A, Muhle C, et al. Correlation between HRCT findings, pulmonary function tests and bronchoalveolar lavage cytology in interstitial lung disease associated with rheumatoid arthritis. Eur Radiol. 2004;14:272-280.
30. Zisman DA, McCune WJ, Tino G, Lynch JP 3rd. Drug-induced pneumonitis: the role of methotrexate. Sarcoidosis Vasc Diffuse Lung Dis. 2001;18:243-252.
31. Nicholson AG, Addis BJ, Bharucha H, et al. Inter-observer variation between pathologists in diffuse parenchymal lung disease. Thorax. 2004;59:500-505.
32. Leslie KO, Trahan S, Gruden J. Pulmonary pathology of the rheumatic diseases. Semin Respir Crit Care Med. 2007;28:369-378.
33. Bjoraker JA, Ryu JH, Edwin MK, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1998;157:199-203.
34. Riha RL, Duhig EE, Clarke BE, et al. Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia. Eur Respir J. 2002;19:1114-1118.
35. Flaherty KR, Toews GB, Travis WD, et al. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J. 2002;19:275-283.
36. Park JH, Kim DS, Park IN, et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med. 2007;175:705-711.
37. Tansey D, Wells AU, Colby TV, et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology. 2004;44:585-596.
38. Hakala M. Poor prognosis in patients with rheumatoid arthritis hospitalized for interstitial lung fibrosis. Chest. 1988;93:114-118.
39. Chang HK, Park W, Ryu DS. Successful treatment of progressive rheumatoid interstitial lung disease with cyclosporine: a case report. J Korean Med Sci. 2002;17:270-273.